Cargando…

Update on genetics and epigenetics in metabolic associated fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is becoming the most frequent chronic liver disease worldwide. Metabolic (dysfunction) associated fatty liver disease (MAFLD) is suggested to replace the nomenclature of NAFLD. For individuals with metabolic dysfunction, multiple NAFLD-related factors also co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiaopeng, Xia, Mingfeng, Gao, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	New Insights in MAFLD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619279/ https://www.ncbi.nlm.nih.gov/pubmed/36325500 http://dx.doi.org/10.1177/20420188221132138

Ejemplares similares

Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
por: Chandra Kumar, C. Vikneshwaran, et al.
Publicado: (2022)

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
por: Kulkarni, Anand V., et al.
Publicado: (2023)

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us
por: Grabherr, Felix, et al.
Publicado: (2022)

Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges
por: Hegarty, Robert, et al.
Publicado: (2023)

MAFLD: a multisystem disease
por: Pipitone, Rosaria Maria, et al.
Publicado: (2023)

Emerging pharmacological treatment options for MAFLD
por: Rojas, Ángela, et al.
Publicado: (2022)

Non-pharmacological management options for MAFLD: a practical guide
por: Stefano, José Tadeu, et al.
Publicado: (2023)

Should we undertake surveillance for HCC in patients with MAFLD?
por: Norero, Blanca, et al.
Publicado: (2023)

Screening for MAFLD: who, when and how?
por: Pal, Shreya C., et al.
Publicado: (2023)

Insidious danger for young adults: Metabolic (dysfunction)-associated fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
por: Yilmaz, Yusuf, et al.
Publicado: (2021)

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis
por: Ergenc, Ilkay, et al.
Publicado: (2021)

The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease
por: Merve Bayram, Hatice, et al.
Publicado: (2021)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
por: Rodríguez-Sanabria, J. Samael, et al.
Publicado: (2022)

An Update on the Ketogenic Diet, 2012
por: Halevy, Ayelet, et al.
Publicado: (2012)

Tracking the evolutionary rise of C(4) metabolism
por: Sage, Rowan F.
Publicado: (2016)

Epigenetics in liver disease
por: Mann, Derek A
Publicado: (2014)

Flavonoid biosynthesis and Arabidopsis genetics: more good music
por: Schäffner, Anton R.
Publicado: (2016)

An evo-devo perspective on root genetic variation in cereals
por: Salvi, Silvio
Publicado: (2017)

The versatility of liver X receptors in T cell homeostasis: Location, location, location!
por: Phan, Truong San, et al.
Publicado: (2021)

Cancer metastasis linked to macrophage size, shape, and metabolism
por: Murray, Peter J.
Publicado: (2020)

Meeting the complexity of plant nutrient metabolism with multi-omics approaches
por: Heyneke, Elmien, et al.
Publicado: (2021)

Nanopore sequencing: a rapid solution for infectious disease epidemics
por: Cao, Ying, et al.
Publicado: (2019)

China in action: national strategies to combat against emerging infectious diseases
por: Han, Min, et al.
Publicado: (2017)

Silencing the silent pandemic: eliminating antimicrobial resistance by using bacteriophages
por: Ye, Mao, et al.
Publicado: (2022)

The Role of Exercises in Osteoporotic Fracture Prevention and Current Care Gaps. Where Are We Now? Recent Updates
por: Senderovich, Helen, et al.
Publicado: (2017)

Microglia in Alzheimer’s disease: Local heroes!
por: Villacampa, Nàdia, et al.
Publicado: (2020)

A promising new γ-secretase modulator for Alzheimer’s disease
por: Dobrowolska Zakaria, Justyna A., et al.
Publicado: (2021)

Implementing immunization program efficiently, and establishing national database of adverse reactions
por: Gao, George Fu
Publicado: (2014)

β-Catenin regulates tumor-derived PD-L1
por: Han, Chuanhui, et al.
Publicado: (2020)

Issues and prospects of image‐guided thermal ablation in the treatment of primary and metastatic lung tumors
por: Wang, Meixiang, et al.
Publicado: (2022)

ZBP1: A STARGᐰTE to decode the biology of Z-nucleic acids in disease
por: Kesavardhana, Sannula, et al.
Publicado: (2020)

Family Reflections: Living with, but not defined by: Posterior urethral valves, chronic kidney disease and kidney transplant
por: Wray, Lucy
Publicado: (2022)

Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need
por: Zhang, Tengyue, et al.
Publicado: (2020)

A quest for long-distance signals: the epidermis as central regulator of pipecolic acid-associated systemic acquired resistance
por: Vlot, A Corina
Publicado: (2021)

A paternal environmental legacy: Evidence for epigenetic inheritance through the male germ line
por: Soubry, Adelheid, et al.
Publicado: (2014)

“Maxillary lateral incisor partial anodontia sequence”: a clinical entity with epigenetic origin
por: Consolaro, Alberto, et al.
Publicado: (2017)

Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
por: Yang, Xinyu, et al.
Publicado: (2021)

Shanghai Autism Early Development: An Integrative Chinese ASD Cohort
por: Dai, Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pdcfrp7ilgdof05utnt774d0re